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1. Introduction  
In general, nucleic acid adducts are formed when harmful chemical compounds react 
covalently with cellular DNA or RNA molecules. With only four natural nucleobases in 
DNA or RNA, identical nucleic acid adducts can theoretically occur at multiple positions 
within the human genome or transcriptome. The frequency of nucleic acid adduction is 
further increased by the reactivity of DNA or RNA to form adducts with many different 
types of chemicals, which include both exogenous compounds that our bodies have been 
exposed and endogenous compounds that are generated through normal metabolic 
activities in our bodies.1,2 Some exogenous compounds may require metabolic activation 
prior to the formation of nucleic acid adducts, whereas others may react directly with 
nucleic acids. If DNA adducts are not effectively removed by the DNA repair mechanism, 
the adducts can directly interfere with DNA replication and transcription.3 Similarly, the 
presence of adducts in RNA molecules can affect their biological functions. From the results 
of many experimental studies, the association of either DNA adducts or RNA adducts to 
cancer have already been well established. In the case of DNA adducts, it is widely 
recognized as the key element for the onset of carcinogenesis. Both DNA adducts and RNA 
adducts are, therefore, important biomarkers for cancer research, which include the 
monitoring of exposure to carcinogens, genetic mutation, DNA repair and so on. Similar to 
the analysis of other cancer biomarkers, both identification and quantification of nucleic acid 
adducts are required. Prior to the detection of nucleic acid adducts, it is important to ensure 
the biological or clinical samples are collected and stored properly. Equally important, the 
isolation of genomic DNA or RNA has to be carried out with high efficiency, which includes 
the yield and purity of selected material, reproducibility and the rate of sample throughput. 
For the detection of nucleic acid adducts, the requirements can be divided into the following 
order: 
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1. Limit of Detection. First and foremost is the ability to detect the presence of the adduct of 
interest. The detection signal that corresponds to a specific adduct should be at least 
two times above the background noise which originates from either the sample matrix 
or electronic components in an analytical instrumentation.  
2. Selectivity. The major analytical challenge for the analysis of nucleic acid adducts is that 
the ratio between unmodified nucleotides and adducts can be as high as 1012 : 1. To 
achieve an accurate measurement, it is very important to be able to select or separate 
the adduct of interest from other nucleotides that have not been modified.  
3. Specificity. For the analysis of nucleic acid adducts, specificity refers to the ability to 
distinguish the target adduct from the other possible adducts, including different 
isomers, that may co-exist in the same sample. In the case of mass spectrometric 
methods, this can be easily achieved by using a mass spectrometer that can provide 
high mass resolution (e.g. Orbitrap from Thermo Scientific).  
4. Quantitation. As mentioned above, it is important to be able to accurately determine the 
amount of target adduct in a biological sample. To achieve absolute quantitation, the 
construction of a calibration graph with the dilutions of a pure standard is required. 
This can be a challenge simply because many pure standards of nucleic acid adducts are 
not available. 
5. Reproducibility. It is important to ensure the method being used to measure a target 
adduct is reproducible which includes both intraday and interday reproducibility. 
6. Sample Throughput. With a wide variety of nucleic acid adducts and their high frequency 
of occurrence in a genome and transcriptome, the number of assays that are required in a 
specific study, especially in a clinical related study, can be relatively high. Thus, it is 
necessary to consider the time which is required to complete every step in the method 
being used as well as how many samples can be processed in parallel at the same time. 
7. Cost. For measuring a relatively high number of samples, the cost of running a 
particular method for each sample can add up to a prohibitive level. In general, the 
higher the sensitivity of the method, the less sample and reagent are required. Also, the 
smaller the number of experimental steps is involved in a selected method, the fewer 
reagents are required.   
To address these challenges for analyzing nucleic acid adducts, a number of different 
methods have been designed and developed.4,5,6,7,8,9 Among those methods, LC-MS is the 
most commonly used analytical technique for carrying out the end point measurements of 
nucleic acid adducts. However, different samples or different adducts often pose their 
unique challenges. In other words, there is no single analytical technique that can be 
considered as a universal technique for detecting nucleic acid adducts. Unlike some of the 
recent publications, in which only the use of one specific analytical technique was discussed, 
this chapter provides an overview of the entire process for analyzing nucleic acid adducts. 
This chapter begins with a section on the introduction and challenges of nucleic acid adduct 
analysis. In the second section, the isolation and initial characterization of genomic DNA or 
specific groups of cellular RNA are discussed. Various analytical methods that have been 
developed for the detection of nucleic acid adducts are discussed in the third and fourth 
section, which also includes the rationale for selecting each detection method. It is, however, 
not our intention to review the analysis of each specific nucleic acid adduct that have been 
reported in the literature.  
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2. Methods 
2.1 Isolation of genomic DNA and specific groups of cellular RNA 
With the advance in the techniques for isolating nucleic acids from cellular samples, the 
analysis of nucleic acids has become an indispensable tool for studying the biological 
processes in different types of living organisms. As shown in Figure 1, sample preparation is 
the most important step preceding any specific type of nucleic acid measurement. For 
instance, the purpose of proper sampling is to ensure that a representative sample is 
collected, whose identity and composition is representative of the true in-situ abundance. 
Equally important, the integrity of DNA and RNA should be preserved to ensure 
trustworthiness and relevance of the data would be obtained in the downstream 
measurements. This section will cover the current methods for isolating cellular DNA or 
RNA with high yields and purity as well as the best practice on storing the samples.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Schematic diagram of work flow for preparing nucleic acid adduct samples  
Sampling and Sample Storage
Tissue or Cell Disruption 
Isolation of DNA or RNA 
Sample purification
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In general, the isolation of nucleic acids is dependent on the efficiency on disrupting the 
tissues or cells, the inactivation of nucleases such as deoxyribonuclease (DNase) or 
ribonuclease (RNase), and the removal of any proteins that may be structurally associated 
with nucleic acids. Since the quality of any downstream process including the nucleic acid 
measurements is dependent on the purity of isolated nucleic acids, great care should be 
taken to avoid any contamination. The most common contaminants include cellular 
proteins, carbohydrates, lipids, or the presence of RNA in isolated DNA and vice versa.10 An 
extensive review on the effects of nucleic acid sample preparations on downstream 
applications was recently published by GE Healthcare.11  
The procedures used for sample preparation prior to the isolation of cellular nucleic acids 
are critical for success. Special care should be taken to prevent sample degradation by 
nucleases during and after isolation. For example, the degradation of a DNA or RNA 
biomolecules may hinder a downstream measurement where the nucleic acid is required to 
bind to a complementary probe such as in microarray analysis. Some indicators of nucleic 
acid degradation or contamination may include extra products in PCR reactions, failure or 
reduced success in steps involving nucleic acid modification or restriction using enzymes. A 
classic signature of nuclease contamination in DNA samples is the characteristic ladder like 
separation or smear when the DNA is electrophoresed in an agarose gel. In some 
circumstances, it is necessary to isolate both genomic DNA and RNA from the same sample 
and this is discussed later in the chapter.12 
Many commercial kits for the isolation of nucleic acids have been developed but the 
challenges of sample preparation still remain. These challenges include the availability of 
very small sample sizes, the ability to eliminate all contaminating materials that may 
interfere with downstream measurements and the fact that degradation of nucleic acids 
starts immediately after sample collection. In some cases, samples are difficult to disrupt so 
as to get to the nucleic acids. It is also challenging to isolate both DNA and RNA from the 
same sample, to isolate small RNA that are less than 200 nucleotides long, to detect nucleic 
acids arising from viruses in collected samples, or to detect RNA transcripts which are 
expressed in low abundance.13 
2.2 Sampling and sample storage 
Prior to the isolation of nucleic acids, it is important to determine which is the nucleic acid of 
interest (i.e. DNA or RNA), the type of sample that will be collected, and an estimate of how 
much nucleic acid materials will be required. The limit of detection of the technique to be 
used for downstream measurements, and its tolerance to contamination should also be 
considered. All these information are needed for choosing the most suitable isolation 
method.14 Nucleic acids have been successfully isolated from tissue, cell culture, bacteria, 
yeast, fungi, virus, soil, fecal samples, and biofluids such as blood, serum, plasma, lymph, 
cerebral spinal fluid, ascites, saliva, urine, and amniotic fluid. Following the collection of 
samples, the general guideline is to begin the process of nucleic acid isolation as quickly as 
possible. In this way, the possible degradation of nucleic acids will be kept to the minimum. 
If immediate isolation is not possible, the tissue or cellular samples can be mixed with a 
stabilizing agent (e.g. RNAlater® from Qiagen) or flash frozen the samples in liquid nitrogen 
and stored at  -80°C. In cases where nucleic acids have to be stored at room temperature for 
extended periods of time, commercial products such as the FTA Cards technology 
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developed by Whatman can be used. In brief, the FTA cards contain chemically conditioned 
cellulose fiber matrices whose composition quickly lyse the cells, inactivate proteins and 
immobilize the nucleic acids thereby protecting the samples from degeneration. Once the 
samples have been spotted on the cards, the cards have to be thoroughly dried and can be 
stored at room temperature for long term archiving. For the FTA cards, the cellular debris is 
washed away and the nucleic acids remain bound to the card. Whereas, for the FTA Elute, 
nucleic acids are eluted from the cards using water at 95°C while contaminants remain 
bound on the cellulose matrix.15 Isolated DNA samples are best stored at -20°C in 1X TE 
buffer. If long term storage is required, the isolated nucleic acids should be dissolved in 70% 
ethanol and stored at -80oC. Prior to storing the samples, the stock solution should be 
divided into small aliquots which can avoid the degradation of the sample during the freeze 
and thaw cycles of the stock solution. It is important to make sure that the buffer used to 
store the nucleic acids is compatible with the downstream experiments such as PCR, mass 
spectrometry etc.16 
2.3 Sample disruption and deactivation of nucleases 
DNA is found within the nucleus of the cell, tightly coil around histone proteins and 
together forming the chromatin, while RNA is present both inside and outside the nucleus. 
The cell membrane forms a protective and selectively permeable layer around the cellular 
contents, protecting them from the extracellular environment. In order to isolate nucleic 
acids from collected samples, the DNA or RNA has to be liberated from the cells first by 
breaking down the cell membrane and forms a cell lysate, a process known as sample 
disruption. Cultured cells can be lysed directly. Whereas, solid samples such as tissue 
sections have to be physically disrupted. Sample disruption should be carried out in such a 
manner that the integrity of nucleic acids is preserved. A high degree of cell membrane 
disruption is desired in order to maximize the yield of isolated nucleic acids and prevent 
problems in subsequent steps such as clogging of purification columns. After sample 
disruption and homogenization, there should be no visible particulates unless the sample 
contained non cellular components such as bones or connective tissue. The cell membranes 
can be disrupted and homogenized in a variety of ways. These disruption methods are 
classified as either mechanical or non-mechanical.17 
2.3.1 Mechanical methods of cell disruption 
Mechanical cell lysis methods involve breaking the samples by shearing force under liquid 
nitrogen. The samples are mechanically ground using equipment such as a French press, 
sonicator, bead mill or homogenizer.18  Mechanical disruption methods can lead to complete 
cell disruption but can also cause heating or foaming of the sample. Mechanical methods are 
used for samples such as animal tissues that require great force to disrupt.19 
2.3.2 Non-mechanical methods of cell disruption 
Non-mechanical methods involve physical, chemical or enzymatic processes. These 
methods can be used for samples such as cultured cells that do not require strong disruption 
methods. Physical ways of disrupting samples include decompression, freeze thaw, osmotic 
shock lysis, desiccation, or thermolysis. For example, the freeze thaw technique uses 
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repeated freezing and thawing of cells to form sharp ice crystals within the cells to disrupt 
the sample.20 Osmotic shock lysis technique is dependent on the changes of hydrostatic 
pressure created by a change in concentration of solutes between a semipermeable cell 
membrane. The osmotic gradient forces water to flow through the cell membrane, and result 
in breaking the cells apart. Chemical methods use detergents, salts, solvents, or chelating 
agents to disrupt the cells. For chemical disruption, chaotropic salts such as guanidinium 
isothiocyanate disrupt cells by providing a less hydrophobic condition in the sample that in 
return weakens the hydrophobic interactions within the cell membrane, thus breaking the 
cell membrane apart. Chaotropic salts also possess the ability to denature nucleases and 
proteins. Detergent chemical based disruption works by disturbing the hydrophobic 
interactions of phospholipids that are part of the cell membranes. Enzymatic methods utilize 
lysozymes and proteases to break down the cell membranes and are mainly used to disrupt 
cell cultures. Enzymatic treatment is typically followed by sonication, and homogenization 
by overtaxing in a lysing buffer.21 
 
Fig. 2. Summary of sample disruption methods. 
Pathological samples are often formalin-fixed and paraffin embedded (FFPE). If FFPE 
samples have to be used for the isolation of nucleic acids, proper deparafinization using an 
organic solvent like xylene should be done first.22 As a general rule, it is advisable to use the 
mildest disruption method possible to avoid mechanical breakdown of nucleic acids, 
perform the isolation within the shortest period of time by using pre-chilled equipment and 
use nuclease inhibitors. The choice of purification method will depend on the desired 
quality and purity of nucleic acids as well as the yield required for downstream analysis. 
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Disruption of frozen samples is best done in liquid nitrogen rather than letting the samples 
thaw for the same reasons of limiting nuclease activity.23 
Usually one of the most important steps towards achieving high quality of nucleic acids is 
the inactivation of nucleases immediately after the sample is disrupted. Naturally occurring 
nucleases in the sample can degrade nucleic acids and therefore, during lysis, it is advisable 
to add a nuclease inhibitor into the lysing buffer. After sample collection, the samples can be 
flash-frozen using liquid nitrogen or homogenized in the presence of nuclease inactivation 
solution. Placing sample in a lysing buffer such as guanidinium isothiocyanate can 
inactivate nucleases. Chelating agents such as EDTA that sequester Mg2+ ions which are 
required for nuclease activity can also be used to prevent nucleic acid degradation by 
nucleases during storage. Treatment of the sample using proteinase K digests and degrades 
all proteins, including nucleases. The breakdown of proteins reduces the viscosity of 
samples and helps in subsequent steps such as filtration.24 Moreover, nucleases are 
ubiquitous and can be found in glassware as well as on our fingers.  Thus, care should also 
be taken to avoid contaminating the samples with exogenous nucleases. The use of a clean 
nuclease-free working area and wearing gloves should always be part of the experimental 
procedure. Likewise, glassware should be sterilized at 250 °C for two hours.25 
2.4 DNA isolation techniques 
Since the first DNA isolation by the Swiss physician Friedrich Miescher in 1869, numerous 
protocols have been developed. DNA isolation begins with cell membrane disruption, 
removal of histone proteins, cell membrane debris and other biomolecules like RNA, lipids 
and proteins. The common DNA isolation methods are either solution based isolation, silica 
based methods or anion exchange. Solution based isolation methods use organic solvents 
such as phenol-chloroform mixture followed by ethanol precipitation. Silica and anion 
exchange based techniques utilize DNA binding media that is in the form of membranes or 
solid phase such as spin columns. Many commercial DNA isolation kits are available in the 
market. The kits use varying protocols and the time for nucleic acid isolation can range from 
a few minutes to few hours depending on the protocol that has been used in the kit. The kits 
typically contain all the required solvents and buffers.26 Numerous studies have been done 
to compare various kits based on hands-on- time, cost per DNA isolation, ease of use, the 
yield and quality. However, when setting up a new project, it is always advisable to 
evaluate different kits for their suitability for the sample of interest from which DNA is to be 
isolated.16 
2.4.1 Solution based extraction techniques 
The most common solution based extraction technique is the phenol-chloroform based 
method which has been extensively used with great success. The phenol-chloroform 
extraction technique depends on phase separation. The lysed samples are mixed with a 
phenol-chloroform solution where DNA or RNA partitions in the aqueous phase depending 
on the pH and salt concentrations of the solutions. If the solution is neutral or basic, RNA 
partitions in the organic phase or in the interface together with proteins, while DNA 
partitions in the aqueous phase. Centrifugation is done to separate the two phases and 
residual phenol can be removed by extracting the purified sample using chloroform. The 
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procedure is completed by precipitating the nucleic acid from the aqueous phase using 
ethanol. This technique is inexpensive, however, it involves the use of phenol which is toxic. 
The presence of residual phenol in the extracted DNA can impact negatively on 
downstream analysis that may involve the use of enzymes. Phenol is neurotoxic and can 
cause severe burns and therefore care must be taken when using it.27 
2.4.2 Silica based extraction techniques 
The silica based techniques that are used by most current methods offer a fast and robust 
method for DNA purification. This technique is dependent on the simple fact that DNA 
adsorbs onto silica surfaces in the presence of high concentrations of chaotropic salts. The 
silica can be in the form of two different formats: particles that are coated on magnetic beads 
or silica columns. Many commercial kits using the silica based technique are available, some 
of which are automated. The buffers used in cell lysis can be chosen in such a manner that 
during adsorption, only DNA adsorbs onto the silica while all other biomolecules such as 
RNA and proteins remain in solution. Cellular debris and other biomolecules are washed 
out using ethanol while the DNA is retained on the silica surface. The DNA is eluted using 
low salt buffer such as Tris-EDTA (TE) or water. Relatively pure DNA can be obtained using 
silica based technique; however, treatment of the purified DNA with RNase to remove 
residual RNA may sometimes be helpful. Care should be taken to wash out all the ethanol 
to make sure that it does not interfere with downstream applications e.g. presence of ethanol 
in DNA samples can cause the sample to “float” out of gel electrophoresis wells causing a 
loss of sample.28 
2.4.3 Anion exchange chromatography 
This purification method relies on the interaction between the negatively charged phosphate 
backbone of DNA and positively charged functional groups found on an anion exchange 
resin. The sample is loaded under low salt concentration to allow DNA to bind. A medium 
strength buffer is used to wash off RNA, proteins and other cellular metabolites. The DNA 
is then eluted using high strength buffer. Additionally, alcohol precipitation can be used for 
desalting as well as concentrating the isolated DNA. Since the DNA is eluted with high salt 
buffer, most downstream applications will require the sample to be desalted. Plasmid DNA 
is routinely precipitated with ethanol; however, ethanol precipitation of genomic DNA 
makes it harder to be redissolved. If desalting or concentration of genomic DNA is required, 
it is best done using isopropanol precipitation or desalting columns.29 
2.5 Characterization of isolated DNA 
Because DNA absorbs at 260nm while protein absorbs at 280 nm, the UV absorbance ratio at 
A260/A280 is generally accepted as a measure of the nucleic acid purity from the 
contamination of any cellular proteins. A ratio of 1.8 and above is considered as good 
quality. Organic compounds and chaotropic salts usually absorb at 230nm and therefore the 
A260/A230 ratio can be used to evaluate the presence of residual contaminants from the 
extraction of DNA. A value of 1.5 and above is considered to be good. A measure of 
turbidity at 320nm can also be used to evaluate presence of contaminants. The quality of 
DNA can be assessed by using gel electrophoresis, which provides valuable information on 
www.intechopen.com
 
Isolation and Detection of Carcinogenic Nucleic Acid Adducts 119 
the integrity of isolated DNA. More vigorous isolation techniques can lead to degradation of 
DNA, which is evident on the gel as a smear of low molecular weight DNA.30 DNA quality 
can also be characterized by using the Agilent 2100 analyzer31 or real time polymerase chain 
reaction (qPCR).32 DNA quantitation is commonly done by UV absorbance. 
Spectrophotometers such as the NanoDrop developed by NanoDrop Technologies are 
capable of utilizing as little as one microliter of sample for absorbance measurements with a 
large dynamic range spanning three orders of magnitude. Usually the conversion factors for 
1 absorbance unit at 260nm are 50µg/mL for double stranded DNA, 33µg/mL for single 
stranded DNA, and 20-30µg/mL for oligonucleotides. Although most quantification work 
on nucleic acids is done using UV absorbance, this method has some sensitivity and 
accuracy limits. A260 measurements can be altered by contaminants such as free nucleotides 
leading to erroneous quantification. Fluorescent dyes that selectively bind DNA have also 
been used for the characterization DNA. In spite of the fact that fluorescent dyes are more 
expensive than using UV absorbance techniques, the benefits of using fluorescent dyes 
outweighs their cost drawback. The dyes have a high affinity for DNA and exhibit increased 
fluorescence enhancement after binding. This enables quantification of very small amounts 
of DNA. The sensitivity can be more than 10,000 times greater than UV absorbance 
measurements. Furthermore, a great advantage of fluorescent dyes over UV is that 
measurements are not affected by the presence of free nucleotides or proteins. Commonly 
used dyes include PicoGreen and OliGreen for DNA.  
2.6 Potential pitfalls of DNA isolation 
Residual cellular RNA can be found in the samples of isolated DNA. This is more common 
when samples are from organs that exhibit more transcriptional activities such as the tissue 
samples of liver or kidney. Since RNA also absorbs UV light at 260 nm, the presence of any 
RNA in DNA samples adversely affect the quantitative UV measurements. The presence of 
RNA in isolated DNA samples also interferes with sequencing and reduces the efficiency of 
amplification. RNA contamination can be eliminated by treating the sample with RNase to 
degrade the RNA. The presence of proteins in isolated DNA samples can be the result of 
incomplete digestion by proteases and interfere with the mobility of DNA during gel 
electrophoresis as well as altering the kinetics of other enzymatic reactions. Residual organic 
solvents such as ethanol, phenol, chloroform etc. will negatively affect most downstream 
procedures while salts will slow down or inhibit enzymatic activity such as restriction 
enzymes. Furthermore, just because a sample contains only DNA is not absolute proof of 
good quality. This is because during isolation, the sample can be contaminated with DNA 
from other sources. Such external DNA will give a false impression during DNA 
quantitation and interfere with amplification procedures.33 
2.7 RNA isolation techniques 
Total RNA can be divided into several groups of RNA which include messenger RNA 
(mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA), mitochondrial RNA (mtRNA) and 
many groups of small RNA such as microRNA (miRNA), and piwi-interacting RNA (piRNA). 
On average, about 80% of total RNA is made up of rRNA while 1-5% is mRNA. Expression of 
mRNA can vary greatly from cell to cell and can range from a few copies per cell to several 
thousand.34 If poly-adenylated mRNA is required, it is preferably isolated from total RNA by 
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capturing the poly(A) tail onto oligo(dT) primers. The same approach can also be used to 
isolate mRNA directly from the lysate without necessarily isolating the total RNA. Similar to 
the isolation of DNA, the requirements for both quality and quantity of isolated RNA would 
determine the choice of isolation method. For example, RNA isolated for use in microarrays 
and RT-PCR needs to be of high purity and free from contaminants such as salts, phenol, 
ethanol etc. whereas methods such as Northern blotting may be more forgiving for 
contaminants. When purifying RNA, it is very important that it is prevented from degradation 
by both endogenous and exogenous RNases. Many commercial kits for RNA isolation have 
been developed, some of them are designed to isolate specific group of RNA, e.g. mRNA. 
The most common solution based technique for RNA isolation is the guanidinium, phenol-
chloroform ethanol precipitation. This technique was first reported by Chomczynski and 
Sacchi in 1987 and later revisited in 2006 by the same authors.35 Over time, the method has 
been widely used and modified. Basically, it operates on the principle that RNA can be 
separated from DNA if an acidic solution containing sodium acetate, phenol, chloroform 
and guanidinium isothiocyanate is used. Guanidinium isothiocyanate is a very effective 
protein denaturant and when used in buffers, it provides an RNase-free environment. 
Phenol dissociates nucleic acids from proteins while chloroform denatures both proteins 
and lipids. Chloroform also makes nucleic acids less soluble in phenol and maintains the 
separation of the aqueous and the organic layer. Mixing the lysate with the acidic solution 
results in phase separation with the RNA partitioning in the upper aqueous layer while the 
DNA, lipids and protein remain either in the interphase or in the lower organic phenol 
layer. The upper aqueous layer is retrieved and the total RNA recovered through 
precipitation with isopropanol. 
2.7.1 Sequence specific RNA isolation 
To capture RNA whose sequence is known, biotinylated DNA probes consisting of a 
sequence complimentary to the known portion of the RNA to be isolated can be used. The 
probe-RNA complex is then isolated using streptavidin coated magnetic beads through the 
interaction of biotin and streptavidin. The beads are pulled out of solution using a magnet, 
and the supernatant containing cellular debris and contaminants is removed. The captured 
RNA is then eluted from the beads for downstream applications.36 
2.7.2 Isolation of mRNA  
To isolate mRNA, a sample containing total RNA is loaded in an oligo(dT) spin column. In 
high salt conditions, the 3’ poly(dA) tail of mRNA hybridize to oligo(dT) that have been 
immobilized on the column. The contaminants are washed off with a high salt buffer and a 
low salt buffer. The mRNA is then eluted using a low ionic strength buffer. Alternatively, 
magnetic beads coated with poly(dT) beads can be added to total RNA sample. The beads are 
captured with a magnet and the contaminants are removed. The bead complex is then washed 
and mRNA are eluted. This technique is also useful for concentrating mRNA samples.37 
2.7.3 Isolation of Small RNA with <200 nucleotides (nt) 
The most widely used techniques for total RNA isolation are phenol or silica based. These 
methods were designed and optimized for isolation of high molecular weight RNA because 
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small RNA molecules were thought to be unimportant. As such, these traditional methods 
do not retain most of the small RNA fraction and are therefore not suitable for the isolation 
of small RNA (<200nt). Since small RNA only makes up a small fraction of total RNA, the 
use of total RNA as starting material for any detection method can potentially lower its 
sensitivity and/or specificity. Small RNA such as microRNA, siRNA, piwiRNA, rasiRNA 
and others have been shown to perform important biological functions. In order to isolate 
these RNA, the traditional methods have been redesigned or completely new methods have 
been developed. Initially, separation and enrichment of small RNA from total RNA was 
done by size fractionation using size exclusion columns or by using 12-15% denaturing 
polyacrylamide gel electrophoresis. These techniques however only yield minute amounts 
of small RNA. The need to isolate larger amounts of small RNA has led to development of 
the new methods. Commercially available kits for small RNA isolation include PureLink 
from Invitrogen (Carlsbad, CA, USA)38, miRNeasy Mini Kit from Qiagen (Valencia, CA, 
USA)39 and mirVana that is produced and sold by Ambion (Austin, Texas, USA)40 among 
others. The mirVana kit makes use of organic as well as solid phase isolation. RNA is first 
isolated from the lysed sample using acidic phenol-chloroform solution that separates RNA 
from proteins, DNA and other cellular debris. The isolated RNA can be further purified for 
small RNA by immobilizing them onto a glass-fiber filter. A low ionic strength buffer is 
used to wash the filter before small RNA is eluted with a relatively low ethanol 
concentration (25%).41 
2.8 Characterization of isolated RNA  
Similar to the characterization of isolated DNA, the traditional method for the quantification 
of RNA is by using UV absorbance measurements. A diluted sample of RNA is measured at 
260 and 280nm. Using the Beer-Lambert law which assumes that the relationship between 
absorbance and concentration is linear, the concentration of RNA can be calculated. An 
absorbance of 1.0 using A260 measurement translates to an RNA concentration of ~40µg/mL. 
The A260/A280 ratio is used as a measure of RNA purity since proteins absorb at A280. A ratio 
of 1.82:1 is accepted as a measure of highly purified RNA. In the presence of DNA 
contamination, UV measurements can overestimate the RNA concentration because DNA 
also absorbs at 260nm, however, if DNA contamination is suspected, the sample should be 
treated with RNase-free DNase to eliminate the DNA. The quantity of RNA can be 
determined by using fluorescent dyes such as RiboGreen and fluorometric measurements. 
This method is less sensitive to free nucleotides and proteins but can be inaccurate in the 
presence of DNA contamination. The integrity of isolated RNA is often measured by using 
denaturing gel electrophoresis. When total RNA sample is run on a denaturing gel stained 
with ethidium bromide, the 28S and 18S rRNA  show up as intense bands. The 28S and 18S 
rRNA band intensity ratio can be used as a measure of the integrity of RNA. A ratio of 2:1 
(28S:18S) is usually accepted as a measure of intact RNA. Smeared 28S and 18S coupled with 
a ratio below 2:1 is an indication of RNA degradation. Highly degraded RNA samples 
appear as a smear in the region of low molecular weight. For limited amounts of RNA 
samples, other RNA staining dyes that are more sensitive such as SYBR Gold and SYBR 
Green can be used.42 A more recent method is the Agilent 2100 Bioanalyzer that uses a 
microfluidics-based platform in conjunction with capillary electrophoresis and fluorescent 
dyes to perform both qualitative and quantitative measurements. The sample size for the 
2100 Bioanalyzer can be as low as 1µL of 10ng/µL RNA.43 
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2.9 Potential pitfalls of RNA isolation 
The presence of RNase causes degradation of RNA and will affect all downstream 
applications that require intact RNA. The presence of polysaccharides especially in liver and 
muscle tissues can affect RNA isolation and lead to low yields. Polysaccharides also inhibit RT-
PCR, though, the mechanism of interference is not known. Residual genomic DNA in isolated 
RNA interferes with RT-PCR, microarrays and even nuclease protection experiments. The 
DNA contaminants can compete for PCR primers or other probes for the detection of RNA 
and lead to false positive signals. DNA is easily removed from the isolated RNA by digesting 
it with DNase. The DNase can be easily removed before downstream experiments are 
performed. Residual EDTA and solvents used to isolate RNA can chelate Mg2+ ions that are 
needed by polymerases in PCR and prevent cDNA synthesis. They can also interfere with 
microarray experiments. Carryover salts from buffers and other solutions slow down reverse 
transcriptase and cDNA synthesis. Alcohol, chloroform and phenol that may be carried over 
during isolation affect most biological experiments by inhibiting enzymatic activity.  
3. Detection and quantificaton of DNA adducts 
Referring to Figure 3, depending upon the type of biological samples, nucleic acid adducts 
can exist at the genomic level (i.e. intact DNA) or individual nucleotide adducts, which 
result from biodegradation and have been excreted into biofluids (e.g. urine).  
For the analysis of genomic DNA, the majority of developed methods require breaking 
down the genomic DNA into monomeric nucleotides or dinucleotides. This can be 
accomplished by either chemical hydrolysis or enzymatic digestion as shown in the 
schematic diagram in Figure 3. With the chemical hydrolysis of genomic DNA, if an acidic 
compound is used, it may induce the depurination of DNA and/or the hydrolysis of DNA 
adducts. Thus, the alternative enzymatic approach is more widely used to digest genomic 
DNA. To ensure a complete digestion of genomic DNA, a combination of different 
nucleases, for instance exonuclease and endonuclease, is often used. Following the digestion 
of genomic DNA, the approach for analyzing DNA adducts is the same for all types of 
biological samples, i.e. DNA adducts are separated from a mixture of nucleotides prior to 
their specific detection.  
The removal of unmodified nucleotides can greatly enhance the specificity of the 
subsequent detection of DNA adducts. This is because, in many studies, the ratio of 
unmodified nucleotides to nucleotide adducts can be as high as 1012 : 1. As indicated in 
Figure 3, the separation of DNA adducts is usually achieved by using one or a combination 
of chromatographic techniques. Often times, this part of an experimental procedure for 
analyzing specific DNA adducts is referred as enrichment of DNA adducts or a solid-phase 
extraction of DNA adducts. After the separation of DNA adducts, there are a number of 
different analytical techniques that have been chosen for carrying out the end point 
measurements of specific DNA adducts as shown in Figure 3. In general, the end point 
measurements can be divided into two groups, namely with or without the use of reporting 
labels. The use of reporting labels, for instance 32P radioactive isotope, can achieve lower 
limit of detection (LOD). On the other hand, the direct adduct measurements, i.e. without 
the use of any reporting labels, can achieve higher specificity and also allow the molecular 
structure of adducts to be determined. The selection of a specific analytical technique is 
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ultimately determined by the physiochemical properties of DNA adduct and its abundance 
in the biological samples. More details on each analytical technique that have been used to 
detect DNA adducts are covered in subsections 3.1.1 to 3.1.5. Readers are advised that the 
aim of this section is to provide an overview of the current methodologies for DNA adduct 
analysis that have been used in the last five years and is not intended to cover all the reports 
in the literature. Several excellent reviews on the detection of specific DNA adducts are 
available in the literature.44,45 
 
Fig. 3. Schematic diagram of different approaches for analyzing DNA adduction. 
It is important to realize that the digestion of genomic DNA into its monomeric nucleotides 
is equivalent to erasing all the DNA sequence information, thus the locations of adduction 
within the genome can no longer be determined. In order to determine the locations of DNA 
adduction, genomic DNA has to be analyzed. There are a number of polymerase chain 
reaction (PCR) based methods that have been developed which allow us to determine the 
locations of adduction. In general, these methodologies rely on using specific enzymatic 
activities or chemical hydrolysis methods to create unique reaction products that 
correspond to each location of DNA adduct. For instance, an adduct-containing DNA 
fragment can be cleaved at or near the adduct by a DNA repair enzyme. The resulting 
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fragments are amplified by using PCR. By sequencing the PCR amplicons, the locations of 
adduct can then be determined. With the use of PCR, very small amounts of starting 
material are required. However, the drawbacks of this approach include the specificity of 
the methods for breaking down the genomic DNA at or near the location of an adduct, the 
lack of information on the adduct identity, and the inability to determine the location of 
adducts that are close or next to each other. Overall, the PCR-based methods are the only 
approach that can be used to determine the location of adducts but may not be universally 
applicable.  
With a wide variety of DNA adductions, there is no single method that can be used to 
analyze every possible DNA adduct. Before spending time and efforts to develop and/or 
validate a method, the extent of DNA damage can be evaluated by a non-specific method 
called comet assay. As indicated in Figure 3, the starting materials for comet assay are tissue 
or cellular samples. In the comet assay, cells are first embedded in an agarose gel. The cells 
are then lysed under a condition that induces DNA to supercoil and link to the nucleus 
matrix. With the presence of DNA damage, it is easier to electrophoretically pull the DNA 
out from the cell nucleus. By using microscopic fluorometry to monitor the migration of 
DNA, which forms a tail resembling a comet, the extent of cellular DNA damage can be 
evaluated. The higher the fluorescence intensity in the tail, the higher the extent of DNA 
damage. Alternatively, for determining the presence of DNA adducts on a tissue section, the 
approach of immunohistochemistry can be used, providing a specific detection antibody 
against the adduct of interest is available.  
3.1 Accelerated Mass Spectrometry (AMS) 
AMS has generally been regarded as the most sensitive method available in the detection of 
DNA adducts with a limit of detection (LOD) ranging from ~1-10 adducts per 1012 
nucleotides.46 In AMS, the abundance of specific radioisotopes is measured. For measuring 
biological samples, the most relevant isotopes are 14C and 3H. The sensitivity of AMS is high 
enough that even very small amounts of exogenously applied radioisotopes can be detected, 
thereby allowing AMS to be used in human studies.47  The sample preparation protocol 
involves the extraction of cellular DNA which can be either analyzed as intact DNA or 
subjected to enzymatic digestion into nucleotides.  This is followed by the separation with 
HPLC to isolate the adduct of interest.  Sample analysis usually involves combustion into 
elemental carbon or CO2 for 14C or titanium hydride for 3H.  However despite the 
aforementioned advantages, AMS has several disadvantages as well. Before the adduct 
measurements, the subject or host has to be exposed to radioactive isotopic-labeled 
precursors. As such, biomonitoring studies are often prohibited.  Since the chemical 
structure of the adduct is lost due to its decomposition into the elemental components, there 
is a requirement to compare the chromatograms of synthetic adducts (if available) with that 
of the sample, to accurately identify the adduct. Significant emphasis must be placed on 
sample purity to prevent the false positive signals from any radioactive background noise. 
Currently, there are a limited number (5-10) of AMS spectrometers worldwide that are 
specifically setup for biological sample analysis.48  To increase the viability to analyze 
samples from humans in terms of possible exposure to unlabeled carcinogenic/genotoxic 
compounds, postlabeling methods have been developed to derivatize DNA adducts of 
interest with 14C or 3H isotopes.46 
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3.2
 32
P radioisotope labeling 
The 32P-postlabeling method is useful in analyzing a vast array of DNA adducts (e.g. 
polycyclic aromatic hydrocarbons, aromatic amines, etc.) and is also highly regarded with 
respect to sensitivity (LOD of 1 adduct/1010 nucleotides). Following the isolation of genomic 
DNA, the sample is enzymatically digested into 3’-mononucleotides or less commonly 
dinucleotides.  Enrichment procedures call for the use of either immunoaffinity 
chromatography or n-butanol as a means to extract adduct from unmodified nucleotides. 
The extracted nucleotide adduct is then dephosphorylated using nuclease P1 treatment.  
Phosphorylation (or 32P-postlabeling) is then performed by the specific activity of T-4 
polynucleotide kinases. This produces 3’,5’-bisphosphates which are subsequently separated 
by using a chromatographic technique such as high performance liquid chromatography 
(HPLC), two-dimensional thin layer chromatography (2D-TLC), or gel separation. 
Resolution is greater for HPLC but sensitivity is lower than  
TLC. Thus, for quantitative analysis, TLC is more common. The initial standardization 
protocols for quantitation purposes in the 1990s were found to be only qualitative.  More 
recently, a method that overcame some of the shortcomings of earlier trials was reported.49  
With efficient isolation of DNA adduct and labeling, quantitation of specific adducts is 
possible. A set of standardized protocols are now instituted and allow quantitation of 
several types of DNA adducts (aromatic amines, PAHs, methylating agents).50  
Nevertheless, the required large quantities of radioactive isotopes and the lengthy time 
necessary for completing the labeling procedure are problematic. Also, structural 
characterization of DNA adduct is not possible, thus rigorous co-chromatography against 
synthetic or previously identified adducts is required to identify DNA adducts.     
3.3 Mass spectrometry 
With the advances in mass spectrometry, the applications of mass spectrometry to analyze 
DNA adducts have continued to grow in the recent years. A number of excellent reviews 
have been published.51 Following the isolation and digestion of genomic DNA, the analysis 
of DNA adducts can be carried out by using either gas chromatography-mass spectrometry 
(GC-MS) or liquid chromatography-mass spectrometry (LC-MS). In the case of GC-MS, the 
less volatile adducts have to be derivatized prior to the GC-MS measurements. Also, owing 
to the thermal decomposition, the analysis of adducts are often limited to nucleobases. With 
the development of soft ionization techniques like electrospray ionization (ESI) and matrix-
assisted laser desorption/ionization (MALDI), liquid chromatography has been successfully 
coupled to mass spectrometry. This allows the accurate mass of specific adducts to be 
measured as well as their molecular structure can be determined by using tandem mass 
spectrometry (MS/MS). Specifically, following the elution of an adduct from a LC column 
and the ionization of adduct, the precursor (or parent) ion of the adduct is selected by the 
first mass analyzer. The precursor ion is then fragmented by a process called collision-
induced dissociation (CID). After that, all the fragment ions which originated from the 
selected adduct are separated and detected in the second mass analyzer. The molecular 
structure of selected adduct including the type and position of adduction can be determined 
with high accuracy by analyzing the MS/MS data. The structural information is very 
desirable as it may provide insight into the metabolism of a genotoxic agent before 
adduction. Additionally, small sample sizes are possible with the LC-MS method. This is in 
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contrast to other methodologies for determining molecular structures, such as nuclear 
magnetic resonance (NMR) spectroscopy which requires larger sample sizes and higher 
concentration of adduct. For the quantitation of adducts, the choice of instrumentation is a 
mass spectrometer that is equipped with a triple quadrupole mass analyzer. To ensure 
sufficient high sensitivity is achieved, nano-electrospray ionization and/or the selected 
reaction monitoring (SRM) mode in a triple quadrupole mass spectrometer are 
recommended. Recently, a two-dimensional linear quadrupole ion trap mass spectrometer 
operating in a constant neutral loss scanning mode with subsequent triple stage MS was 
utilized in the detection and quantitation of five different DNA adducts.52  This technique 
was demonstrated to be capable of screening various carcinogenic adducts at low LOD (~1 
adduct per 108 nucleotides) with small quantities of DNA (~10 μg). This is an order of 
magnitude more sensitive than the best available immunoassays and close to that of 32P-
postlabeling method. Several reports have been published in which ESI MS has been 
coupled to capillary electrophoresis (CE) or nanoLC, thereby providing the capability to 
examine adducts at low levels. For example, an LOD of ~5 adducts per 109nucleosides with 
a linear dynamic range between 70 amol and 70 fmol has recently been reported.53 
3.4 Fluorometric and electrochemical detection  
Following the chromatographic separation of adducts, their detection can be achieved by 
fluorescence, electrochemical (EC), or electron capture detection (ECD) providing the 
adducts have either intrinsic or chemically induced properties to generate the corresponding 
signals. In general, the sensitivity of these techniques are often in the range of 1-10 adducts 
per 108 nucleotides and require ~20-100 µg of genomic sample. If pure standards are 
available, structural characterization as well as the quantitation of adducts are possible. 
However, the number of adducts which have the required intrinsic physiochemical 
properties are limited. Also, the derivatization (or labeling) of adducts which lack the 
intrinsic properties to generate the corresponding signals is labor intensive and the yield is 
usually low. These techniques have been used to detect adducts with inherent fluorescence 
property (e.g. PAH and aflatoxin B1) or electrochemical characteristics (e.g. 8-oxo-7,8-
dihydroguanine). Providing the adduct has a derivatizable group in comparison to 
unmodified DNA, the derivatization of adduct with a volatile ligand, such as 
pentafluorophenyl, would allow the use of GC which is coupled to an electron capture 
detector, whose sensitivity can be as low as zeptomole.54  Similar sensitivity can also be 
achieved by using laser induced fluorescence (LIF) providing the phosphate group of a 
nucleotide containing the adduct has been derivatized with an appropriate fluorophore.  
3.5 Immunoassay 
As mentioned earlier, antibodies can be used to detect DNA adducts in a wide variety of 
tissue samples (immunohistochemistry). The same antibody can be applied to the detection 
of digested or excreted DNA adducts in various biofluids by using an enzyme linked 
immunosorbent assay (ELISA) assay or an equivalent immunoassay. Various antibodies 
against adducts with either high or low molecular weight are available. However, in clinical 
studies, the specificity of antibodies to recognize adducts is relatively poor. This is partly 
due to the fact that DNA adducts are not separated from the other unmodified nucleotides 
or cellular components before being measured by immunoassay. To address this technical 
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issue, trapped in agarose DNA immunostaining (TARDIS) assay has been developed. An 
extensive review of this topic has been discussed.55 In general, monoclonal antibodies are 
preferred over polyclonal antibodies with regards to specificity but polyclonal antibodies 
can provide higher sensitivity (1 adduct per 108 nucleotides). The overall assay sensitivity is 
dependent on the affinity of antibody for the adduct of interest and the detectability of 
reporting label being used.   
4. Detection and quantificaton RNA adducts 
In comparison to the DNA adduct analysis, the number of reports on RNA adduct analysis 
are significantly less. This could be partly due to the fact that, unlike the genomic DNA, 
cellular RNAs are not used as templates to generate any biological molecules. Furthermore, 
there is a natural turnover of cellular RNA, i.e. the gene expression and degradation of RNA 
are continuous processes within the cells. Owing to these reasons, the effects of RNA 
adduction have often been considered to be less important than DNA adduction. 
Nevertheless, RNA adduction has been associated with different diseases which include 
cancer. The same methods that have been used to detect DNA adducts can also be applied 
to the detection and quantification of RNA adducts. To ensure higher specificity is achieved, 
it is important to remove any genomic DNA from cellular RNA samples prior to the RNA 
adduct analysis. As mentioned earlier in this chapter, the most effective approach to remove 
genomic DNA is by carrying out the DNase digestion, and the intact cellular RNA that 
remains in the sample can be easily purified by using one of the standard RNA purification 
methods. After that, cellular RNA is ready to be digested into nucleotides, unless the 
information on the location of RNA adducts is desired. To determine the location of adducts 
within an RNA fragment, the PCR-based methods can be used. For instance, reverse 
transcriptase would prematurely stop the cDNA synthesis at the adduct location and 
produce a template which is unique to the adduct location for the subsequent PCR reaction. 
In general, the PCR-based methods have lower specificity than those methods that have 
been developed to analyze a mixture of nucleotides including RNA adducts.  
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